<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05107232</url>
  </required_header>
  <id_info>
    <org_study_id>35RC21_8958_OSV-IRM</org_study_id>
    <nct_id>NCT05107232</nct_id>
  </id_info>
  <brief_title>OSV-IRM - Volunteer MRI Sequence Optimization</brief_title>
  <acronym>OSV-IRM</acronym>
  <official_title>OSV-IRM - Volunteer MRI Sequence Optimization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optimization of magnetic resonance imaging (MRI) protocols on healthy volunteers and&#xD;
      voluntary patients.&#xD;
&#xD;
      In MRI, a large number of technical parameters (sequence, parameters in sequence, antenna,&#xD;
      reconstruction method, etc.) can be changed to optimize the diagnostic quality of the exam.&#xD;
      Some optimizations can be performed on participants healthy volunteers, others need to be&#xD;
      carried out on images pathological and acquired in voluntary patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An inclusion visit is planned to verify the criteria for selection, then an imaging visit to&#xD;
      perform the MRI examination.&#xD;
&#xD;
      The imaging visit can take place at the end of the inclusion visit and until the following 15&#xD;
      days. For healthy volunteers, the visits are organized according to their availability. For&#xD;
      patients, on the other hand, participation in the research will depend on the programming of&#xD;
      the MRI within the framework care.&#xD;
&#xD;
      This is a single-center prospective study carried out at two sites in the Rennes University&#xD;
      Hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 4, 2021</start_date>
  <completion_date type="Anticipated">December 2027</completion_date>
  <primary_completion_date type="Anticipated">November 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of MRI signal</measure>
    <time_frame>15 days</time_frame>
    <description>The quality of the images, maps or signals collected will be compared to standard acquisitions. This evaluation will be done by statistical comparison of visual qualitative criteria by expert radiologists or on quantitative criteria drawn from analyzes computing data obtained by processing experts images (signal-to-noise ratio, contrast-to-noise ratio, blur level, mutual information, co-location of regions highlighted by different techniques, etc.).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>MRI</condition>
  <arm_group>
    <arm_group_label>Participants</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients and Healthy volunteers included will have an MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI</description>
    <arm_group_label>Participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Criteria common to all participants:&#xD;
&#xD;
               -  Minor or major subject&#xD;
&#xD;
               -  Affiliated, himself or through his parents if he is a minor, to a a social&#xD;
                  security scheme&#xD;
&#xD;
               -  Having given their free, informed and written consent, and/or which the free,&#xD;
                  informed and written consent of the holder(s) parental authority has been&#xD;
                  obtained for minors&#xD;
&#xD;
        Specific criteria for healthy volunteers:&#xD;
&#xD;
        o No medical or surgical history related to the anatomical area(s) scanned&#xD;
&#xD;
        Specific criteria for voluntary patients:&#xD;
&#xD;
        o Indication for an MRI exam as part of its management&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Contraindication to an MRI (pacemaker or pacemaker, neurostimulator, intra-orbital&#xD;
             metal body, vascular clip ferromagnetic)&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Legal protection measure for adults in progress (safeguard of justice, guardianship,&#xD;
             curatorship) or subject deprived of liberty&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Christophe FERRE, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Blandine Gautier</last_name>
    <phone>299282591</phone>
    <phone_ext>+33</phone_ext>
    <email>blandine.gautier@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Christophe Ferre, Pr</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Blandine Gautier</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Christophe Ferre, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

